Central, Eastern Europe Lead OTC Growth On Sector’s Top Continent
This article was originally published in The Tan Sheet
Executive Summary
Central and Eastern Europe continue to drive OTC sales growth on the continent, with even low-growth countries matching the best levels in Western Europe.
You may also be interested in...
Aurobindo Accesses Russian OTC Market Through Deal With Diod
Indian company Aurobindo Pharma stakes a claim in Russia’s surging consumer health product market with a joint venture to market OTC and generic drugs.
GSK Divests Non-Core OTCs To Focus On "Priority Brands," Emerging Markets
GlaxoSmithKline will divest non-core OTC products to accelerate consumer health care growth and help fund a share buy-back program following a financial wipeout in the firm's most recent quarter.
Sanofi Acquires BMP Sunstone To Expand Chinese Consumer Health Portfolio
Sanofi-Aventis gains a leadership position in China's OTC cough/cold market with its $520.6 million acquisition of BMP Sunstone, the latest in the global pharma's parade of consumer health buys.